Industrial - Pollution & Treatment Controls
Compare Stocks
4 / 10Stock Comparison
ZWS vs RXO vs CHRW vs FELE
Revenue, margins, valuation, and 5-year total return — side by side.
Trucking
Integrated Freight & Logistics
Industrial - Machinery
ZWS vs RXO vs CHRW vs FELE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Industrial - Pollution & Treatment Controls | Trucking | Integrated Freight & Logistics | Industrial - Machinery |
| Market Cap | $8.55B | $3.81B | $20.33B | $4.41B |
| Revenue (TTM) | $1.74B | $4.31B | $16.20B | $2.18B |
| Net Income (TTM) | $213M | $-69M | $599M | $150M |
| Gross Margin | 43.7% | 17.5% | 8.3% | 35.2% |
| Operating Margin | 17.4% | -0.2% | 4.9% | 12.6% |
| Forward P/E | 29.0x | — | 27.9x | 21.8x |
| Total Debt | $581M | $861M | $1.63B | $280M |
| Cash & Equiv. | $301M | $18M | $161M | $100M |
ZWS vs RXO vs CHRW vs FELE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 22 | May 26 | Return |
|---|---|---|---|
| Zurn Elkay Water So… (ZWS) | 100 | 217.3 | +117.3% |
| RXO, Inc. (RXO) | 100 | 110.2 | +10.2% |
| C.H. Robinson World… (CHRW) | 100 | 175.4 | +75.4% |
| Franklin Electric C… (FELE) | 100 | 122.0 | +22.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ZWS vs RXO vs CHRW vs FELE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ZWS is the #2 pick in this set and the best alternative if long-term compounding and valuation efficiency is your priority.
- 435.0% 10Y total return vs FELE's 231.4%
- PEG 0.91 vs CHRW's 5.20
- Better valuation composite
- 12.3% margin vs RXO's -1.6%
RXO is the clearest fit if your priority is growth exposure.
- Rev growth 26.2%, EPS growth 72.8%, 3Y rev CAGR 6.2%
- 26.2% revenue growth vs CHRW's -8.4%
CHRW carries the broadest edge in this set and is the clearest fit for dividends and momentum.
- 1.4% yield, 5-year raise streak, vs FELE's 1.1%, (1 stock pays no dividend)
- +98.6% vs FELE's +17.7%
- 11.5% ROA vs RXO's -2.9%, ROIC 18.0% vs -0.2%
FELE is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 32 yrs, beta 0.92, yield 1.1%
- Lower volatility, beta 0.92, Low D/E 21.1%, current ratio 2.79x
- Beta 0.92, yield 1.1%, current ratio 2.79x
- Beta 0.92 vs RXO's 2.74, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 26.2% revenue growth vs CHRW's -8.4% | |
| Value | Better valuation composite | |
| Quality / Margins | 12.3% margin vs RXO's -1.6% | |
| Stability / Safety | Beta 0.92 vs RXO's 2.74, lower leverage | |
| Dividends | 1.4% yield, 5-year raise streak, vs FELE's 1.1%, (1 stock pays no dividend) | |
| Momentum (1Y) | +98.6% vs FELE's +17.7% | |
| Efficiency (ROA) | 11.5% ROA vs RXO's -2.9%, ROIC 18.0% vs -0.2% |
ZWS vs RXO vs CHRW vs FELE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ZWS vs RXO vs CHRW vs FELE — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ZWS leads in 2 of 6 categories
RXO leads 1 • CHRW leads 1 • FELE leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ZWS leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CHRW is the larger business by revenue, generating $16.2B annually — 9.3x ZWS's $1.7B. ZWS is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to RXO's -1.6%. On growth, ZWS holds the edge at +11.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $1.7B | $4.3B | $16.2B | $2.2B |
| EBITDAEarnings before interest/tax | $371M | $77M | $896M | $322M |
| Net IncomeAfter-tax profit | $213M | -$69M | $599M | $150M |
| Free Cash FlowCash after capex | $321M | $9M | $858M | $169M |
| Gross MarginGross profit ÷ Revenue | +43.7% | +17.5% | +8.3% | +35.2% |
| Operating MarginEBIT ÷ Revenue | +17.4% | -0.2% | +4.9% | +12.6% |
| Net MarginNet income ÷ Revenue | +12.3% | -1.6% | +3.7% | +6.9% |
| FCF MarginFCF ÷ Revenue | +18.4% | +0.2% | +5.3% | +7.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.4% | -99.9% | -0.8% | +9.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +40.0% | -16.7% | +9.9% | +13.4% |
Valuation Metrics
RXO leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 30.8x trailing earnings, FELE trades at a 33% valuation discount to ZWS's 45.6x P/E. Adjusting for growth (PEG ratio), ZWS offers better value at 1.43x vs CHRW's 6.62x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $8.6B | $3.8B | $20.3B | $4.4B |
| Enterprise ValueMkt cap + debt − cash | $8.8B | $4.7B | $21.8B | $4.6B |
| Trailing P/EPrice ÷ TTM EPS | 45.57x | -39.24x | 35.48x | 30.75x |
| Forward P/EPrice ÷ next-FY EPS est. | 29.04x | — | 27.86x | 21.77x |
| PEG RatioP/E ÷ EPS growth rate | 1.43x | — | 6.62x | 3.53x |
| EV / EBITDAEnterprise value multiple | 23.41x | 42.72x | 24.28x | 13.82x |
| Price / SalesMarket cap ÷ Revenue | 5.04x | 0.66x | 1.25x | 2.07x |
| Price / BookPrice ÷ Book value/share | 5.45x | 2.53x | 11.28x | 3.41x |
| Price / FCFMarket cap ÷ FCF | 27.01x | — | 22.72x | 22.81x |
Profitability & Efficiency
CHRW leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
CHRW delivers a 33.3% return on equity — every $100 of shareholder capital generates $33 in annual profit, vs $-6 for RXO. FELE carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to CHRW's 0.88x. On the Piotroski fundamental quality scale (0–9), ZWS scores 7/9 vs FELE's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +13.4% | -5.9% | +33.3% | +11.4% |
| ROA (TTM)Return on assets | +8.0% | -2.9% | +11.5% | +7.6% |
| ROICReturn on invested capital | +11.3% | -0.2% | +18.0% | +14.7% |
| ROCEReturn on capital employed | +12.0% | -0.3% | +25.6% | +18.1% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.36x | 0.56x | 0.88x | 0.21x |
| Net DebtTotal debt minus cash | $280M | $843M | $1.5B | $181M |
| Cash & Equiv.Liquid assets | $301M | $18M | $161M | $100M |
| Total DebtShort + long-term debt | $581M | $861M | $1.6B | $280M |
| Interest CoverageEBIT ÷ Interest expense | 11.08x | -3.15x | 6.27x | 24.75x |
Total Returns (Dividends Reinvested)
ZWS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ZWS five years ago would be worth $20,799 today (with dividends reinvested), compared to $11,024 for RXO. Over the past 12 months, CHRW leads with a +98.6% total return vs FELE's +17.7%. The 3-year compound annual growth rate (CAGR) favors ZWS at 34.3% vs FELE's 3.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +9.2% | +80.3% | +5.1% | +3.6% |
| 1-Year ReturnPast 12 months | +50.2% | +78.2% | +98.6% | +17.7% |
| 3-Year ReturnCumulative with dividends | +142.5% | +19.6% | +73.6% | +10.0% |
| 5-Year ReturnCumulative with dividends | +108.0% | +10.2% | +84.1% | +20.3% |
| 10-Year ReturnCumulative with dividends | +435.0% | +10.2% | +163.6% | +231.4% |
| CAGR (3Y)Annualised 3-year return | +34.3% | +6.2% | +20.2% | +3.2% |
Risk & Volatility
Evenly matched — RXO and FELE each lead in 1 of 2 comparable metrics.
Risk & Volatility
FELE is the less volatile stock with a 0.92 beta — it tends to amplify market swings less than RXO's 2.74 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RXO currently trades 99.4% from its 52-week high vs CHRW's 84.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.11x | 2.74x | 0.95x | 0.92x |
| 52-Week HighHighest price in past year | $53.76 | $23.29 | $203.34 | $111.53 |
| 52-Week LowLowest price in past year | $33.95 | $10.43 | $86.58 | $83.42 |
| % of 52W HighCurrent price vs 52-week peak | +94.9% | +99.4% | +84.3% | +89.6% |
| RSI (14)Momentum oscillator 0–100 | 57.5 | 62.5 | 42.9 | 54.8 |
| Avg Volume (50D)Average daily shares traded | 1.0M | 1.9M | 1.7M | 281K |
Analyst Outlook
Evenly matched — CHRW and FELE each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ZWS as "Hold", RXO as "Hold", CHRW as "Hold", FELE as "Hold". Consensus price targets imply 9.3% upside for CHRW (target: $187) vs -30.9% for RXO (target: $16). For income investors, CHRW offers the higher dividend yield at 1.45% vs ZWS's 0.73%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $54.71 | $16.00 | $187.38 | $100.00 |
| # AnalystsCovering analysts | 8 | 20 | 46 | 11 |
| Dividend YieldAnnual dividend ÷ price | +0.7% | — | +1.4% | +1.1% |
| Dividend StreakConsecutive years of raises | 3 | — | 5 | 32 |
| Dividend / ShareAnnual DPS | $0.37 | — | $2.48 | $1.11 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.9% | +0.0% | +1.7% | +3.8% |
ZWS leads in 2 of 6 categories (Income & Cash Flow, Total Returns). RXO leads in 1 (Valuation Metrics). 2 tied.
ZWS vs RXO vs CHRW vs FELE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ZWS or RXO or CHRW or FELE a better buy right now?
For growth investors, RXO, Inc.
(RXO) is the stronger pick with 26. 2% revenue growth year-over-year, versus -8. 4% for C. H. Robinson Worldwide, Inc. (CHRW). Franklin Electric Co. , Inc. (FELE) offers the better valuation at 30. 8x trailing P/E (21. 8x forward), making it the more compelling value choice. Analysts rate Zurn Elkay Water Solutions Corporation (ZWS) a "Hold" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ZWS or RXO or CHRW or FELE?
On trailing P/E, Franklin Electric Co.
, Inc. (FELE) is the cheapest at 30. 8x versus Zurn Elkay Water Solutions Corporation at 45. 6x. On forward P/E, Franklin Electric Co. , Inc. is actually cheaper at 21. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Zurn Elkay Water Solutions Corporation wins at 0. 91x versus C. H. Robinson Worldwide, Inc. 's 5. 20x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ZWS or RXO or CHRW or FELE?
Over the past 5 years, Zurn Elkay Water Solutions Corporation (ZWS) delivered a total return of +108.
0%, compared to +10. 2% for RXO, Inc. (RXO). Over 10 years, the gap is even starker: ZWS returned +435. 0% versus RXO's +10. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ZWS or RXO or CHRW or FELE?
By beta (market sensitivity over 5 years), Franklin Electric Co.
, Inc. (FELE) is the lower-risk stock at 0. 92β versus RXO, Inc. 's 2. 74β — meaning RXO is approximately 199% more volatile than FELE relative to the S&P 500. On balance sheet safety, Franklin Electric Co. , Inc. (FELE) carries a lower debt/equity ratio of 21% versus 88% for C. H. Robinson Worldwide, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ZWS or RXO or CHRW or FELE?
By revenue growth (latest reported year), RXO, Inc.
(RXO) is pulling ahead at 26. 2% versus -8. 4% for C. H. Robinson Worldwide, Inc. (CHRW). On earnings-per-share growth, the picture is similar: RXO, Inc. grew EPS 72. 8% year-over-year, compared to -15. 8% for Franklin Electric Co. , Inc.. Over a 3-year CAGR, ZWS leads at 9. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ZWS or RXO or CHRW or FELE?
Zurn Elkay Water Solutions Corporation (ZWS) is the more profitable company, earning 11.
7% net margin versus -1. 7% for RXO, Inc. — meaning it keeps 11. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ZWS leads at 17. 0% versus -0. 1% for RXO. At the gross margin level — before operating expenses — ZWS leads at 41. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ZWS or RXO or CHRW or FELE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Zurn Elkay Water Solutions Corporation (ZWS) is the more undervalued stock at a PEG of 0. 91x versus C. H. Robinson Worldwide, Inc. 's 5. 20x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Franklin Electric Co. , Inc. (FELE) trades at 21. 8x forward P/E versus 29. 0x for Zurn Elkay Water Solutions Corporation — 7. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CHRW: 9. 3% to $187. 38.
08Which pays a better dividend — ZWS or RXO or CHRW or FELE?
In this comparison, CHRW (1.
4% yield), FELE (1. 1% yield), ZWS (0. 7% yield) pay a dividend. RXO does not pay a meaningful dividend and should not be held primarily for income.
09Is ZWS or RXO or CHRW or FELE better for a retirement portfolio?
For long-horizon retirement investors, Franklin Electric Co.
, Inc. (FELE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 92), 1. 1% yield, +231. 4% 10Y return). RXO, Inc. (RXO) carries a higher beta of 2. 74 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (FELE: +231. 4%, RXO: +10. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ZWS and RXO and CHRW and FELE?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ZWS is a small-cap quality compounder stock; RXO is a small-cap high-growth stock; CHRW is a mid-cap quality compounder stock; FELE is a small-cap quality compounder stock. ZWS, CHRW, FELE pay a dividend while RXO does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.